Search

Danaher Corp

Atvērts

SektorsVeselības aprūpe

230.4 0.59

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

224.9

Max

230.68

Galvenie mērījumi

By Trading Economics

Ienākumi

-159M

870M

Pārdošana

314M

6.3B

P/E

Sektora vidējais

40.005

49.241

EPS

1.94

Dividenžu ienesīgums

0.63

Peļņas marža

13.887

Darbinieki

58,000

EBITDA

353M

1.8B

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+8.55% upside

Dividendes

By Acuity

Dividenžu ienesīgums

Sektora vidējais

0.63%

2.15%

Nākamais dividenžu datums

2026. g. 30. okt.

Nākamais Ex dividenžu datums

2026. g. 25. dec.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

15B

158B

Iepriekšējā atvēršanas cena

229.81

Iepriekšējā slēgšanas cena

230.4

Danaher Corp Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 22. okt. 22:02 UTC

Correlated Moves
News

Danaher Corp reported a revenue miss due to $80M in tariff-related adjustments and raised its full-year adjusted earnings guidance amid a conservative outlook.

2026. g. 21. okt. 23:36 UTC

Danaher Corp's shares are modestly lower in after-market trading, retracing from a brief peak shortly after the market closed.

2026. g. 20. okt. 23:02 UTC

Danaher Corp declined during after-market trading, continuing a trend of four consecutive sessions closing lower amid persistent downward pressure.

2026. g. 19. okt. 20:01 UTC

News
Correlated Moves

Danaher Corporation is set to report third-quarter earnings on October 21, with analysts expecting $1.92 per share and $6.56 billion in revenue.

2026. g. 17. okt. 00:01 UTC

Danaher Corp is trading higher in after-market hours, reaching its highest cumulative return of the session and significantly above its 20-day moving average.

2026. g. 16. okt. 23:31 UTC

Danaher Corp shares are trading lower in after-market hours, reflecting a broader market decline amid persistent inflationary pressures indicated by today's economic data.

2026. g. 15. okt. 21:02 UTC

Danaher Corp shares declined modestly in after-market trading, following a volatile session that saw the stock turn lower after initial gains.

2026. g. 14. okt. 23:41 UTC

Danaher Corp is trading modestly higher in after-market hours, continuing a trend of five consecutive sessions of gains and remaining above its 20-day moving average.

2026. g. 13. okt. 23:01 UTC

Danaher Corp is trading modestly higher in after-market hours, maintaining a position well above its 20-day moving average despite notable fluctuations.

2026. g. 12. okt. 23:26 UTC

News

Danaher Corporation appoints Daniel L. Comas and Robert Hershberg, M.D., Ph.D., to its Board of Directors, expanding it from 11 to 13 members.

2026. g. 9. okt. 20:06 UTC

Correlated Moves

Danaher Corp shares are advancing, aligning with broader market gains and a rise in the life sciences sector, bolstered by positive developments at Repligen Corp.

2026. g. 8. okt. 23:01 UTC

Danaher Corp shares declined modestly in after-market hours, falling below Thursday's close amid unusual trading behavior and remaining in the middle of its one-month range.

2026. g. 7. okt. 23:00 UTC

Danaher Corp's shares traded lower in after-market hours, declining before slightly recovering, while remaining near the middle of their one-month trading range.

2026. g. 6. okt. 22:21 UTC

Danaher Corp's shares advanced modestly in after-market hours, reflecting broader market gains and positioning above its 20-day moving average.

2026. g. 5. okt. 23:15 UTC

Danaher Corp's shares are trading modestly lower in after-market hours, down from Monday's close despite a minor recovery earlier in the session.

2026. g. 2. okt. 20:03 UTC

Danaher Corp is advancing, continuing its upward trend since Thursday's close, despite pulling back from an earlier session high.

2026. g. 1. okt. 23:35 UTC

Danaher Corp is trading slightly lower in after-market hours, extending a trend of declines over the past four consecutive sessions.

2026. g. 30. sept. 23:00 UTC

Danaher Corp has advanced in after-market trading, moving significantly higher from a flat start and positioned well above its 20-day moving average.

2026. g. 29. sept. 20:21 UTC

Danaher Corp is trading modestly lower in after-market hours, declining after an initial uptick, despite being above its 20-day moving average.

2026. g. 28. sept. 23:01 UTC

Danaher Corp's shares are trading modestly lower in after-market hours, continuing a decline since Monday's close and remaining at their lowest point during this session.

2026. g. 26. sept. 00:01 UTC

Danaher Corp is declining in after-market trading, moving lower since Friday's close, ending a streak of five consecutive higher sessions.

2026. g. 25. sept. 20:12 UTC

Danaher Corp is trading modestly lower in after-market hours, maintaining a loss since Friday's close despite being above its 20-day moving average.

2026. g. 24. sept. 23:01 UTC

Danaher Corp is trading modestly lower in after-market hours, following a notable decline that resulted in a significantly negative cumulative return for the day.

2026. g. 23. sept. 22:36 UTC

Danaher Corp is lower in after-market trading, showing a slight recovery after a decline earlier in the session, remaining near its one-month range.

2026. g. 22. sept. 20:07 UTC

Social Media
News

Danaher Corp shares reached a four-week high today, marking the highest price since August 2026, supported by strong online commentary and strategic adjustments.

2026. g. 21. sept. 22:41 UTC

Danaher Corp's shares declined modestly in after-market trading, reversing an initial uptick, but remain above their 20-day moving average.

2026. g. 18. sept. 20:06 UTC

Correlated Moves

Danaher Corp shares fell modestly as the market trades lower, influenced by a slight decline in Thermo Fisher Scientific after an early high.

2026. g. 17. sept. 23:31 UTC

Danaher Corp is experiencing a modest rise in after-market trading, remaining above its 20-day moving average and near the upper end of its one-month range.

2026. g. 16. sept. 20:10 UTC

News
Correlated Moves

Danaher Corporation's shares are modestly lower despite the launch of research-grade S.p. Cas9 mRNA by its subsidiaries Integrated DNA Technologies and Aldevron.

2026. g. 15. sept. 23:01 UTC

Danaher Corp shares are lower in after-hours trading amid volatility. The New York Empire State Manufacturing Index fell sharply, impacting investor sentiment.

Salīdzinājums

Cenas izmaiņa

Danaher Corp Prognoze

Cenas mērķis

By TipRanks

8.55% augšup

Prognoze 12 mēnešiem

Vidējais 253.857 USD  8.55%

Augstākais 275 USD

Zemākais 200 USD

Pamatojoties uz 14 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Danaher Corp — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

14 ratings

13

Pirkt

1

Turēt

0

Pārdot

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Danaher Corp

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company has a research collaboration with Stanford University's Department of Bioengineering for cancer drug development. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.
help-icon Live chat